Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CTOR will decline by -62.78% over the next 2 Weeks and hit $0.64 by Thursday, August 28, 2025. In that time frame, CTOR's share price is expected to range between - and $1.66.
BearishAverageBullishCTOR shares fell -1.74% in Friday, August 15, 2025's trading session, dropping from a previous close of $1.72 to move at $1.69. The stock demonstrated notable intraday movement (see CTOR's key stats for a full breakdown), fluctuating between $1.66 and $1.72, a +3.58% trading range. While recent weeks have seen some volatility, CTOR has managed to secure a -17.96% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 277.44K shares changing hands, 109.04K more than the previous session. This amounted to $468.87K in total market activity.
Will CTOR Continue Its Downward Trend?
According to analyst ratings and projections for CTOR, Citius Oncology, Inc. shares are anticipated to decrease by -1.70%, potentially reaching $1.66 per share by August 28, 2025. Short-term technical indicators for CTOR currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the CTOR stock forecast, now is not the best time to buy CTOR stock because its current trading price is +164.02% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CTOR covering social and institutional perspectives.
CTOR Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CTOR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 37.48% to 44.10%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 55.69%, suggests a neutral medium-term outlook. Meanwhile, the 100-day RSI, at 135.86%, indicates a bearish outlook for the long term. Insights into CTOR's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Citius Oncology Short-Term Forecasts
CTOR Forecast For Next 5 Days
Our algorithm anticipates Citius Oncology (CTOR) stock could hit $2.53 by Aug 22, 2025. This represents a +49.50% fall from today's price, following a -4.86% change over the past five days.
CTOR Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Citius Oncology, Inc. (CTOR) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $2.57, which would mean a +52.07% increase from the current price of $1.69. Projections for this period range from a high of $5.22 to a low of $0.20.
CTOR Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Citius Oncology's price over the next three months point to a drop. CTOR stock is expected to peak at $0.98 on Sep 18, 2025 before potentially dipping to - on Nov 14, 2025. On average, CTOR is likely to trade around - in the coming 90 days.
Citius Oncology Stock Forecast 2025
Based on our predictive models, Citius Oncology (CTOR) is expected to trade between - and $0.98 throughout 2025. This would result in an average price of -, potentially offering investors a -100.00% return from current levels.
Citius Oncology, Inc. Monthly Forecast 2025–2026
August 2025
According to our latest forecast models, Citius Oncology, Inc. (CTOR) is positioned to show a strong performance in August 2025. The price is predicted to move between $0.00 and $0.89, settling at an average of $0.00. This could translate to a -100.00% loss.
September 2025
Based on current market signals, Citius Oncology, Inc. is projected to trend september 2025. We forecast a trading range from $0.00 to $0.98, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
October 2025
Our predictive algorithms indicate Citius Oncology, Inc. stock may see a shift in October 2025. The expected range spans $0.00–$0.86, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
November 2025
Analyzing established trends, Citius Oncology, Inc. looks set to move in November 2025. Projections place the stock between $0.00 and $0.87, averaging around $0.00. This suggests a -100.00% loss from current levels.
December 2025
Market indicators suggest Citius Oncology, Inc. could experience notable changes during December 2025. Prices could fluctuate within $0.00 to $0.81, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
January 2026
Forecasting for January 2026, models estimate that Citius Oncology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.90, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
February 2026
According to our latest forecast models, Citius Oncology, Inc. (CTOR) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.00 and $0.89, settling at an average of $0.00. This could translate to a -100.00% loss.
March 2026
Based on current market signals, Citius Oncology, Inc. is projected to trend march 2026. We forecast a trading range from $0.00 to $0.85, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
April 2026
Our predictive algorithms indicate Citius Oncology, Inc. stock may see a shift in April 2026. The expected range spans $0.00–$0.95, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
May 2026
Analyzing established trends, Citius Oncology, Inc. looks set to move in May 2026. Projections place the stock between $0.00 and $0.85, averaging around $0.00. This suggests a -100.00% loss from current levels.
June 2026
Market indicators suggest Citius Oncology, Inc. could experience notable changes during June 2026. Prices could fluctuate within $0.00 to $0.90, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
July 2026
Forecasting for July 2026, models estimate that Citius Oncology, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.89, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
August 2026
According to our latest forecast models, Citius Oncology, Inc. (CTOR) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $0.85, settling at an average of $0.00. This could translate to a -100.00% loss.
CTOR's history of dividends and stock splits also plays a role in long-term investor confidence.